Hepatitis: Types, Symptoms, and Modern Approaches to Liver Treatment

Introduction: What is Hepatitis?

Hepatitis is an inflammatory disease of the liver that can be caused by various factors, but most often it is triggered by viruses [8]. There are several types of viral hepatitis, designated by the letters A, B, C, D, E, G, each of which has its own characteristics. According to studies, up to 50% of hepatitis cases are caused by the hepatitis A virus [8]. Common symptoms of viral hepatitis often resemble the flu, which can make timely diagnosis difficult [8]. Understanding the various types of hepatitis, their symptoms, transmission routes, and treatment methods is critical for effectively combating this disease and maintaining liver health.

Hepatitis A: Transmission Routes, Symptoms, and Prevention

The hepatitis A virus (HAV) is an RNA virus transmitted via the fecal-oral route [1]. Infection occurs through contaminated food, water, or through direct contact with an infected person [1, 7]. Outbreaks are often associated with poor sanitation, overcrowding, or contamination of food and water sources [1]. Among men who have sex with men, hepatitis A can be sexually transmitted [7].

The clinical manifestations of hepatitis A largely depend on the patient's age. In children, the infection is often asymptomatic, whereas in adults it usually manifests prominently [1, 2]. About 80% of adult patients experience severe hepatitis with a marked increase in liver enzyme levels [2]. Typical symptoms include jaundice (yellowing of the skin and sclera), abdominal pain, general malaise, and elevated blood bilirubin levels [1].

Although in most cases hepatitis A has a favorable course, serious complications are possible. Rare but dangerous forms include fulminant hepatitis (acute liver failure), which occurs in 0.015-0.5% of cases [2]. Atypical manifestations such as relapsing hepatitis, prolonged cholestasis, and even acute kidney injury may be observed [2]. In some cases, hepatitis A can trigger the development of autoimmune hepatitis [6]. Extrahepatic manifestations have also been reported, including autoimmune hemolytic anemia, aplastic anemia, pleural or pericardial effusion, and acute reactive arthritis [2].

Diagnosis of hepatitis A is based on detecting IgM class antibodies to HAV in the blood [1]. Treatment is predominantly supportive and aimed at relieving symptoms [1, 6]. Prevention is the key method in combating hepatitis A. Vaccination is the primary measure to prevent infection and should be carried out whenever possible before potential exposure to the virus [1]. Improving sanitation and observing personal hygiene rules also play an important role [1, 2].

Hepatitis B and D: Characteristics and Interrelationship

The hepatitis B virus (HBV) is one of the most common causes of chronic hepatitis and is considered a sexually transmitted disease [8]. It can also be transmitted through blood and from mother to child. Reactivation of viral infections, including hepatitis B, is common in patients with oncological diseases or haematological malignancies, especially during immunosuppressive therapy [3]. In such cases, antiviral prophylaxis can be effective [3]. Treatment for hepatitis B may include the use of interferon alfa (IFN-α) and nucleoside/nucleotide analogues such as lamivudine, tenofovir, and adefovir dipivoxil [5].

Hepatitis D (HDV) is a so-called "incomplete" virus that can only replicate in the presence of the hepatitis B virus [8]. This means that HDV infection is only possible in people already infected with HBV. Co-infection with HBV and HDV often leads to a more severe disease course and accelerated progression to cirrhosis and liver failure.

Hepatitis C: Chronic Course and Therapy

Hepatitis C (HCV) is known for its ability to cause chronic liver inflammation, which can lead to serious long-term consequences, including cirrhosis and liver cancer. Sources indicate the importance of screening and treating HCV in patients with comorbid conditions, such as inflammatory bowel disease (IBD) [5]. In one study, the prevalence of chronic HCV infection among IBD patients was 0.8% [5]. Hepatitis C therapy traditionally included the combined use of interferon alfa and ribavirin [5], although modern treatment protocols have evolved significantly, offering highly effective interferon-free regimens.

Hepatitis E: Less Known, but Dangerous

The hepatitis E virus (HEV), like HAV, is transmitted via the fecal-oral route [7]. In some regions, especially in Asia, HEV is an important cause of acute severe hepatitis [7]. It can cause acute liver failure (ALF) and acute-on-chronic liver failure (ACLF) [7]. HEV poses a particular danger to pregnant women, in whom HEV-1 infection can lead to ALF [7]. Immunocompromised patients are also at risk of developing chronic hepatitis and ACLF when infected with HEV [7].

Diagnosis and General Principles of Treatment

Early diagnosis of viral hepatitis is crucial for preventing serious complications. Common flu-like symptoms, such as fatigue, nausea, and fever, can be the first signs of hepatitis [8]. Laboratory blood tests are used to confirm the diagnosis, including determining the levels of liver enzymes (ALT, AST), bilirubin, and specific viral markers (antibodies and/or viral RNA/DNA) [1, 2, 6].

The treatment of viral hepatitis depends heavily on the virus type and the stage of the disease. For hepatitis A and E, supportive therapy aimed at relieving symptoms and maintaining liver function is generally used [1, 6]. In cases of hepatitis B and C, especially during a chronic course, antiviral drugs are used, which can significantly improve prognosis and prevent disease progression [5]. It is important to note that even in acute hepatitis A, in the event of autoimmune hepatitis development, conservative treatments such as ursodeoxycholic acid and silymarin may be used [6].

Hepatitis Prevention: The Key to Liver Health

Prevention is the most effective way to combat viral hepatitis. The main measures include:

• Vaccination: Effective vaccines against hepatitis A and B are available [1, 2]. Vaccination against hepatitis A is especially important for individuals traveling to endemic areas and risk groups [1].
• Hygiene: Thorough handwashing, consuming clean water, and safe food help prevent the spread of hepatitis A and E, which are transmitted via the fecal-oral route [1, 7].
• Safe Sex: Using barrier contraception methods reduces the risk of hepatitis B transmission and, in some cases, hepatitis A [7, 8].
• Avoiding Contact with Blood: Do not share needles, razors, toothbrushes, and other items that may contain traces of blood to prevent the transmission of hepatitis B and C.
• Screening: Regular screening for viral hepatitis is recommended for risk groups, including patients with immunodeficiency states or chronic diseases such as inflammatory bowel disease [3, 4, 5].

Remember that seeking medical attention promptly upon the appearance of any suspicious symptoms and following prevention recommendations significantly reduces the risk of developing and progressing viral hepatitis.

Sources

1. Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention. https://pubmed.ncbi.nlm.nih.gov/32389358/
2. Hepatitis A: clinical manifestations and management. https://pubmed.ncbi.nlm.nih.gov/20068336/
3. Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). https://pubmed.ncbi.nlm.nih.gov/26193852/
4. Primary Immunodeficiency and the Gut. https://pubmed.ncbi.nlm.nih.gov/31046971/
5. Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. https://pubmed.ncbi.nlm.nih.gov/21122543/
6. Acute Hepatitis A-Induced Autoimmune Hepatitis: A Case Report and Literature Review. https://pubmed.ncbi.nlm.nih.gov/35888564/
7. Hepatitis A and E Viruses Are Important Agents of Acute Severe Hepatitis in Asia: A Narrative Review. https://pubmed.ncbi.nlm.nih.gov/40430774/
8. Hepatitis A, B, and D. https://pubmed.ncbi.nlm.nih.gov/10855119/

The information presented in this article is for reference purposes only and cannot replace professional medical advice. Always consult a qualified specialist for diagnosis and treatment.